0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Understanding how race may influence the association between A1c and glycemia can improve diabetes screening. We sought to determine whether, for a given A1c level, glucose levels during an oral glucose tolerance test (OGTT) differed by race.

          Research design and methods

          From data collected at 22 US clinical sites, we conducted a cross-sectional study of concurrently measured A1c and OGTT and observational longitudinal follow-up of the subset with high-risk pre-diabetes. Numerical integration methods were used to calculate area under the glycemic curve (AUC glu) during OGTT and least squares regression model to estimate A1c for a given AUC glu by race, controlling for potential confounders.

          Results

          1016 black, 2658 white, and 193 Asian persons at risk of diabetes were included in cross-sectional analysis. Of these, 2154 with high-risk pre-diabetes were followed for 2.5 years. For a given A1c level, AUC glu was lower in black versus white participants. After adjustment for potential confounders, A1c levels for a given AUC glu quintile were 0.15–0.20 and 0.02–0.19 percentage points higher in black and Asian compared with white participants, respectively (p<0.05). In longitudinal analyses, black participants were more likely to be diagnosed with diabetes by A1c than white participants (28% vs 10%, respectively; p<0.01). Black and Asian participants were less likely to be diagnosed by fasting glucose than white participants (16% vs 15% vs 37%, respectively; p<0.05). Black participants with A1c levels in the lower-level quintiles had greater increase in A1c over time compared with white participants.

          Conclusions

          Use of additional testing beyond A1c to screen for diabetes may better stratify diabetes risk in the diverse US population.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          International physical activity questionnaire: 12-country reliability and validity.

          Physical inactivity is a global concern, but diverse physical activity measures in use prevent international comparisons. The International Physical Activity Questionnaire (IPAQ) was developed as an instrument for cross-national monitoring of physical activity and inactivity. Between 1997 and 1998, an International Consensus Group developed four long and four short forms of the IPAQ instruments (administered by telephone interview or self-administration, with two alternate reference periods, either the "last 7 d" or a "usual week" of recalled physical activity). During 2000, 14 centers from 12 countries collected reliability and/or validity data on at least two of the eight IPAQ instruments. Test-retest repeatability was assessed within the same week. Concurrent (inter-method) validity was assessed at the same administration, and criterion IPAQ validity was assessed against the CSA (now MTI) accelerometer. Spearman's correlation coefficients are reported, based on the total reported physical activity. Overall, the IPAQ questionnaires produced repeatable data (Spearman's rho clustered around 0.8), with comparable data from short and long forms. Criterion validity had a median rho of about 0.30, which was comparable to most other self-report validation studies. The "usual week" and "last 7 d" reference periods performed similarly, and the reliability of telephone administration was similar to the self-administered mode. The IPAQ instruments have acceptable measurement properties, at least as good as other established self-reports. Considering the diverse samples in this study, IPAQ has reasonable measurement properties for monitoring population levels of physical activity among 18- to 65-yr-old adults in diverse settings. The short IPAQ form "last 7 d recall" is recommended for national monitoring and the long form for research requiring more detailed assessment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

            Long-term microvascular and neurologic complications cause major morbidity and mortality in patients with insulin-dependent diabetes mellitus (IDDM). We examined whether intensive treatment with the goal of maintaining blood glucose concentrations close to the normal range could decrease the frequency and severity of these complications. A total of 1441 patients with IDDM--726 with no retinopathy at base line (the primary-prevention cohort) and 715 with mild retinopathy (the secondary-intervention cohort) were randomly assigned to intensive therapy administered either with an external insulin pump or by three or more daily insulin injections and guided by frequent blood glucose monitoring or to conventional therapy with one or two daily insulin injections. The patients were followed for a mean of 6.5 years, and the appearance and progression of retinopathy and other complications were assessed regularly. In the primary-prevention cohort, intensive therapy reduced the adjusted mean risk for the development of retinopathy by 76 percent (95 percent confidence interval, 62 to 85 percent), as compared with conventional therapy. In the secondary-intervention cohort, intensive therapy slowed the progression of retinopathy by 54 percent (95 percent confidence interval, 39 to 66 percent) and reduced the development of proliferative or severe nonproliferative retinopathy by 47 percent (95 percent confidence interval, 14 to 67 percent). In the two cohorts combined, intensive therapy reduced the occurrence of microalbuminuria (urinary albumin excretion of > or = 40 mg per 24 hours) by 39 percent (95 percent confidence interval, 21 to 52 percent), that of albuminuria (urinary albumin excretion of > or = 300 mg per 24 hours) by 54 percent (95 percent confidence interval 19 to 74 percent), and that of clinical neuropathy by 60 percent (95 percent confidence interval, 38 to 74 percent). The chief adverse event associated with intensive therapy was a two-to-threefold increase in severe hypoglycemia. Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

              (1998)
                Bookmark

                Author and article information

                Journal
                BMJ Open Diabetes Res Care
                BMJ Open Diabetes Res Care
                bmjdrc
                bmjdrc
                BMJ Open Diabetes Research & Care
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2052-4897
                2024
                12 February 2024
                : 12
                : 1
                : e003613
                Affiliations
                [1 ] Ringgold_6682Kaiser Permanente Center for Health Research , Portland, Oregon, USA
                [2 ] departmentDivision of Endocrinology, Diabetes and Metabolism , Ringgold_1867Tufts Medical Center , Boston, Massachusetts, USA
                [3 ] Ringgold_1867Tufts Medical Center , Boston, Massachusetts, USA
                [4 ] departmentInternal Medicine , Duke University , Durham, North Carolina, USA
                [5 ] departmentEndocrinology, Metabolism and Diabetes , Ringgold_12225University of Colorado Denver School of Medicine , Aurora, Colorado, USA
                [6 ] departmentEndocrinology , Ringgold_19982VA Eastern Colorado Health Care System , Denver, Colorado, USA
                [7 ] departmentMedicine/Endocrinology, Metabolism, and Lipids , Emory University School of Medicine , Atlanta, Georgia, USA
                [8 ] departmentTranslational Research Institute , AdventHealth Research Institute , Orlando, Florida, USA
                [9 ] University of Nebraska Medical Center , Omaha, Nebraska, USA
                [10 ] Ringgold_370076Northwestern Medicine , Chicago, Illinois, USA
                [11 ] departmentEndocrinology , USC , Manhattan Beach, California, USA
                [12 ] departmentDivision of Endocrinology, Diabetes & Metabolism General Clinical Research Center , University of Tennessee Health Science Center , Memphis, Tennessee, USA
                [13 ] Ringgold_14464Pennington Biomedical Research Center , Baton Rouge, Louisiana, USA
                Author notes
                [Correspondence to ] Dr Erin S LeBlanc; Erin.S.LeBlanc@ 123456kpchr.org
                Author information
                http://orcid.org/0000-0002-4067-3432
                http://orcid.org/0000-0002-0124-7174
                http://orcid.org/0000-0003-1269-3580
                http://orcid.org/0000-0002-2912-1389
                http://orcid.org/0000-0001-6660-0568
                http://orcid.org/0000-0001-5318-9677
                http://orcid.org/0000-0003-2832-3429
                Article
                bmjdrc-2023-003613
                10.1136/bmjdrc-2023-003613
                10862329
                38350671
                71028416-93da-4e55-bb52-37344b436c7f
                © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 14 July 2023
                : 12 January 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: U01DK098245
                Funded by: FundRef http://dx.doi.org/10.13039/100000041, American Diabetes Association;
                Award ID: 1-14-D2d-01
                Categories
                Cardiovascular and Metabolic Risk
                1506
                1870
                Custom metadata
                unlocked

                a1c,diabetes mellitus, type 2
                a1c, diabetes mellitus, type 2

                Comments

                Comment on this article